DF/HCC Program Affiliation

Cancer Epidemiology
Breast Cancer
Outcomes Research

DF/HCC Associations

DFCI Breast Program chair, Clinical Trial Chairs

Research Abstract

Dr. Winer's research focus relates to clinical research in breast cancer. In this regard, he conducts a wide variety of phase I, II, and III trials for patients with all stages of breast cancer. In addition, he has interests related to quality of life, psychosocial aspects of cancer, medical decision-making, and doctor-patient communication. Either as a principal investigator or in collaboration with others, he has conducted research in these areas.

Publications

• Punglia RS, Morrow M, Winer EP, Harris JR.Local therapy and survival in breast cancer.N Engl J Med 2007 Jun 7;356(23):2399-405.
  17554121
• Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz R, Winer E.Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.Psychooncology 2007 May 24.
  17525937
• Carlson RW, Anderson BO, Burstein HJ, Carter WB, Edge SB, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Ljung BM, Kiel K, Marks LB, McCormick B, Nabell LM, Pierce LJ, Reed EC, Silver SM, Smith ML, Somlo G, Theriault RL, Ward JH, W
  17439758
• Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ.Surveillance testing among survivors of early-stage breast cancer.J Clin Oncol 2007 Mar 20;25(9):1074-81.
  17369571
• Lin NU, Winer EP.Brain metastases: the HER2 paradigm.Clin Cancer Res 2007 Mar 15;13(6):1648-55.
  17363517
• Harris LN, You F, Schnitt SJ, Witkiewicz A, Lu X, Sgroi D, Ryan PD, Come SE, Burstein HJ, Lesnikoski BA, Kamma M, Friedman PN, Gelman R, Iglehart JD, Winer EP.Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early bre
  17317830
• Tolaney SM, Partridge AH, Sheib RG, Burstein HJ, Winer EP.Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer.J Clin Oncol 2006 Nov 20;24(33):5330-1.
  17114668
• Leining MG, Gelber S, Rosenberg R, Przypyszny M, Winer EP, Partridge AH.Menopausal-type symptoms in young breast cancer survivors.Ann Oncol 2006 Dec;17(12):1777-82.
  16971671
• Burstein HJ, Overmoyer B, Gelman R, Silverman P, Savoie J, Clarke K, Dumadag L, Younger J, Ivy P, Winer EP.Rebeccamycin analog for refractory breast cancer: a randomized phase II trial of dosing schedules.Invest New Drugs 2007 Apr;25(2):161-4.
  16969707
• Carlson RW, Moench SJ, Hammond ME, Perez EA, Burstein HJ, Allred DC, Vogel CL, Goldstein LJ, Somlo G, Gradishar WJ, Hudis CA, Jahanzeb M, Stark A, Wolff AC, Press MF, Winer EP, Paik S, Ljung BM,.HER2 testing in breast cancer: NCCN Task Force report and re
  16813731
• Burstein HJ, Mayer E, Patridge AH, O'Kane H, Litsas G, Come SE, Hudis CA, Goldstein DF, Muss HB, Winter EP, Garber JE.Inadvertent use of aromatase inhibitors in patients with breast cancer with residual ovarian function: cases and lessons.Clin Breast Canc
  16800976
• Hudis CA, Winer EP.Cancer and leukemia group B breast committee: decades of progress and plans for the future.Clin Cancer Res 2006 Jun 1;12(11 Pt 2):3576s-80s.
  16740788
• Punglia RS, Kuntz KM, Winer EP, Weeks JC, Burstein HJ.The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.Cancer 2006 Jun 15;106(12):2576-82
  16703595
• Berry DA, Cirrincione C, Henderson IC, Citron ML, Budman DR, Goldstein LJ, Martino S, Perez EA, Muss HB, Norton L, Hudis C, Winer EP.Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.JAMA 2006 Apr 1
  16609087
• Carlson RW, Brown E, Burstein HJ, Gradishar WJ, Hudis CA, Loprinzi C, Mamounas EP, Perez EA, Pritchard K, Ravdin P, Recht A, Somlo G, Theriault RL, Winer EP, Wolff AC,.NCCN Task Force Report: Adjuvant Therapy for Breast Cancer.J Natl Compr Canc Netw 2006
  16507275
• Come SE, Buzdar AU, Ingle JN, Arteaga CL, Brown M, Dowsett M, Hilsenbeck SG, Kumar R, Johnston SR, Lee AV, Paik S, Pritchard KI, Winer EP, Hart C.Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Thera
  16467115
• Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ.Factors related to underuse of surveillance mammography among breast cancer survivors.J Clin Oncol 2006 Jan 1;24(1):85-94.
  16382117
• Lin NU, Gelman R, Winer EP.Dose density in breast cancer: a simple message?.J Natl Cancer Inst 2005 Dec 7;97(23):1712-4.
  16333021
• Peppercorn J, Partridge A, Burstein HJ, Winer EP.Standards for follow-up care of patents with breast cancer.Breast 2005 Dec;14(6):500-8.
  16288876
• Burstein HJ, Bellon JR, Galper S, Lu HM, Kuter I, Taghian AG, Wong J, Gelman R, Bunnell CA, Parker LM, Garber JE, Winer EP, Harris JR, Powell SN.Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophos
  16243442
• Parmigiani G, Berry DA, Winer EP, Tebaldi C, Iglehart JD, Prosnitz LR.Is axillary lymph node dissection indicated for early-stage breast cancer? A decision analysis.J Clin Oncol 1999 May;17(5):1465-73.
  10334532
• Krop IE, Winer EP.Ten years of HER2-directed therapy: still questions after all these years.Breast Cancer Res Treat 2008 May 8.
  18463974
• Punglia RS, Burstein HJ, Winer EP, Weeks JC.Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.Journal of the National Cancer Institute 2008 May 7;100(9):642-8.
  18445827
• Lin NU, Carey LA, Liu MC, Younger J, Come SE, Ewend M, Harris GJ, Bullitt E, Van den Abbeele AD, Henson JW, Li X, Gelman R, Burstein HJ, Kasparian E, Kirsch DG, Crawford A, Hochberg F, Winer EP.Phase II trial of lapatinib for brain metastases in patients
  18421051
• Wong JS, Taghian AG, Bellon JR, Keshaviah A, Smith BL, Winer EP, Silver B, Harris JR.Tangential Radiotherapy Without Axillary Surgery in Early-Stage Breast Cancer: Results of a Prospective Trial.Int J Radiat Oncol Biol Phys 2008 Apr 2.
  18394815
• Stokes ME, Thompson D, Montoya EL, Weinstein MC, Winer EP, Earle CC.Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data.Value Health 2008 Mar-Apr;11(2):213-20.
  18380633
• Seidman AD, Berry D, Cirrincione C, Harris L, Muss H, Marcom PK, Gipson G, Burstein H, Lake D, Shapiro CL, Ungaro P, Norton L, Winer E, Hudis C.Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with
  18375893
• Lin NU, Winer EP.Optimizing endocrine therapy for estrogen receptor-positive breast cancer: treating the right patients for the right length of time.J Clin Oncol 2008 Apr 20;26(12):1919-21.
  18332468
• Paskett ED, Herndon JE 2nd, Day JM, Stark NN, Winer EP, Grubbs SS, Pavy MD, Shapiro CL, List MA, Hensley ML, Naughton MA, Kornblith AB, Habin KR, Fleming GF, Bittoni MA.Applying a conceptual model for examining health-related quality of life in long-term
  18314912
• Ligibel JA, Campbell N, Partridge A, Chen WY, Salinardi T, Chen H, Adloff K, Keshaviah A, Winer EP.Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors.J Clin Oncol 2008 Feb 20;26(6):907-12.
  18281663
• Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, de Moor JS, Weeks J, Emmons K, Winer E.Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.Journal of the Nati
  18270338
• Lin NU, Winer EP.Advances in adjuvant endocrine therapy for postmenopausal women.J Clin Oncol 2008 Feb 10;26(5):798-805.
  18258989
• Gralow JR, Zujewski JA, Winer E.Preoperative therapy in invasive breast cancer: reviewing the state of the science and exploring new research directions.J Clin Oncol 2008 Feb 10;26(5):696-7.
  18258975
• Gralow JR, Burstein HJ, Wood W, Hortobagyi GN, Gianni L, von Minckwitz G, Buzdar AU, Smith IE, Symmans WF, Singh B, Winer EP.Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.J Clin Oncol
  18258991
• Perez EA, Suman VJ, Davidson NE, Sledge GW, Kaufman PA, Hudis CA, Martino S, Gralow JR, Dakhil SR, Ingle JN, Winer EP, Gelmon KA, Gersh BJ, Jaffe AS, Rodeheffer RJ.Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or
  18250349
• Liu MC, Demetri GD, Berry DA, Norton L, Broadwater G, Robert NJ, Duggan D, Hayes DF, Henderson IC, Lyss A, Hopkins J, Kaufman PA, Marcom PK, Younger J, Lin N, Tkaczuk K, Winer EP, Hudis CA.Dose-escalation of filgrastim does not improve efficacy: Clinical
  18234424
• Razzak AR, Lin NU, Winer EP.Heterogeneity of breast cancer and implications of adjuvant chemotherapy.Breast Cancer 2008;15(1):31-4.
  18224391
• Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A.Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer.J Clin Oncol 2008 Feb 1;26(4):556-62.
  18180462
• Gralow J, Ozols RF, Bajorin DF, Cheson BD, Sandler HM, Winer EP, Bonner J, Demetri GD, Curran W Jr, Ganz PA, Kramer BS, Kris MG, Markman M, Mayer RJ, Raghavan D, Ramsey S, Reaman GH, Sawaya R, Schuchter LM, Sweetenham JW, Vahdat LT, Davidson NE, Schilsky
  18086794
• Buzdar AU, Coombes RC, Goss PE, Winer EP.Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer.Cancer 2008 Feb 1;112(3 Suppl):700-9.
  18072256
• Come SE, Buzdar AU, Ingle JN, Johnston SR, Brodie AM, Coombes RC, Miller WR, Pritchard KI, Winer EP, Zujewski JA, Goss PE.Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference.Cancer 2008 Feb 1;112(3 Su
  18072254
• Lin NU, Winer EP.Optimal use of aromatase inhibitors: to lead or to follow?.J Clin Oncol 2007 Jul 1;25(19):2639-41.
  17563391
• Partridge A, Gelber S, Gelber RD, Castiglione-Gertsch M, Goldhirsch A, Winer E.Age of menopause among women who remain premenopausal following treatment for early breast cancer: Long-term results from International Breast Cancer Study Group Trials V and V
  17512721
• Bullitt E, Lin NU, Ewend MG, Zeng D, Winer EP, Carey LA, Smith JK.Tumor therapeutic response and vessel tortuosity: preliminary report in metastatic breast cancer.Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv 2006;9(
  17354817
• Lin NU, Parker LM, Come SE, Burstein HJ, Haldoupis M, Ryabin N, Gelman R, Winer EP, Shulman LN.Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions.In
  17345004
• Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz R, Winer E.Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.Psychooncology 2007 Oct;16(10):895-903.
  17245695
• Harris LN, Broadwater G, Lin NU, Miron A, Schnitt SJ, Cowan D, Lara J, Bleiweiss I, Berry D, Ellis M, Hayes DF, Winer EP, Dressler L.Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: resu
  17129383
• Rincon M, Broadwater G, Harris L, Crocker A, Weaver D, Dressler L, Berry D, Sutton L, Michaelson R, Messino M, Kirshner J, Fleming G, Winer E, Hudis C, Appel S, Norton L, Muss H,.Interleukin-6, multidrug resistance protein-1 expression and response to pac
  16773437
• Burstein HJ, Parker LM, Keshaviah A, Doherty J, Partridge AH, Schapira L, Ryan PD, Younger J, Harris LN, Moy B, Come SE, Schumer ST, Bunnell CA, Haldoupis M, Gelman R, Winer EP.Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for do
  16293865
• Meyerhardt JA, Heseltine D, Campos H, Holmes MD, Willett WC, Winer EP, Enzinger PC, Bunnell CA, Kulke MH, Fuchs CS.Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapy.J Clin Oncol 2005 Nov 20;23(33):8453-60.
  16293876
• Stryker JE, Wray RJ, Emmons KM, Winer E, Demetri G.Understanding the decisions of cancer clinical trial participants to enter research studies: Factors associated with informed consent, patient satisfaction, and decisional regret.Patient Educ Couns 2005 O
  16242898
• Burstein HJ, Lieberman G, Slamon DJ, Winer EP, Klein P.Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy.Ann Oncol 2005 Nov;16(11):1772-7.
  16150805
• Punglia RS, Kuntz KM, Winer EP, Weeks JC, Burstein HJ.Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.J Clin Oncol 2005 Aug 1;23(22):5178-87.
  15998905
• Partridge AH, Winer EP.Fertility after breast cancer: questions abound.J Clin Oncol 2005 Jul 1;23(19):4259-61.
  15824413
• Partridge AH, Wong JS, Knudsen K, Gelman R, Sampson E, Gadd M, Bishop KL, Harris JR, Winer EP.Offering participants results of a clinical trial: sharing results of a negative study.Lancet 2005 Mar 12-18;365(9463):963-4.
  15766998
• Winer EP.Optimizing endocrine therapy for breast cancer.J Clin Oncol 2005 Mar 10;23(8):1609-10.
  15755964
• Burstein HJ, Winer EP.HER2 or Not HER2: That Is the Question.J Clin Oncol 2005 Feb 28.
  15738533
• Robert NJ, Vogel CL, Henderson IC, Sparano JA, Moore MR, Silverman P, Overmoyer BA, Shapiro CL, Park JW, Colbern GT, Winer EP, Gabizon AA.The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer.Sem
  15717740
• Partridge AH, Winer EP.Long-term complications of adjuvant chemotherapy for early stage breast cancer.Breast Dis 2004;21:55-64.
  15687723
• Winer EP, Hudis C, Burstein HJ, Wolff AC, Pritchard KI, Ingle JN, Chlebowski RT, Gelber R, Edge SB, Gralow J, Cobleigh MA, Mamounas EP, Goldstein LJ, Whelan TJ, Powles TJ, Bryant J, Perkins C, Perotti J, Braun S, Langer AS, Browman GP, Somerfield MR.Ameri
  15545664
• Winer EP, Berry DA, Woolf S, Duggan D, Kornblith A, Harris LN, Michaelson RA, Kirshner JA, Fleming GF, Perry MC, Graham ML, Sharp SA, Keresztes R, Henderson IC, Hudis C, Muss H, Norton L.Failure of higher-dose paclitaxel to improve outcome in patients wit
  15169793
• Elkin EB, Weinstein MC, Winer EP, Kuntz KM, Schnitt SJ, Weeks JC.HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis.J Clin Oncol 2004 Mar 1;22(5):854-63.
  14990641
• Keating NL, Landrum MB, Ayanian JZ, Winer EP, Guadagnoli E.Consultation with a medical oncologist before surgery and type of surgery among elderly women with early-stage breast cancer.J Clin Oncol 2003 Dec 15;21(24):4532-9.
  14673040
• Burstein HJ, Harris LN, Marcom PK, Lambert-Falls R, Havlin K, Overmoyer B, Friedlander RJ, Gargiulo J, Strenger R, Vogel CL, Ryan PD, Ellis MJ, Nunes RA, Bunnell CA, Campos SM, Hallor M, Gelman R, Winer EP.Trastuzumab and vinorelbine as first-line therapy
  12885806
• Burstein HJ, Demetri GD, Mueller E, Sarraf P, Spiegelman BM, Winer EP.Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study.Breast Cancer Res Treat 2003 Jun;79(3)
  12846423
• Bendell JC, Domchek SM, Burstein HJ, Harris L, Younger J, Kuter I, Bunnell C, Rue M, Gelman R, Winer E.Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.Cancer 2003 Jun 15;97(12):2972-7.
  12784331
• Winer EP, Hudis C, Burstein HJ, Bryant J, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gelber R, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP.American Society of Clinical Oncology tec
  12732612
• Earle CC, Burstein HJ, Winer EP, Weeks JC.Quality of non-breast cancer health maintenance among elderly breast cancer survivors.J Clin Oncol 2003 Apr 15;21(8):1447-51.
  12697865
• Citron ML, Berry DA, Cirrincione C, Hudis C, Winer EP, Gradishar WJ, Davidson NE, Martino S, Livingston R, Ingle JN, Perez EA, Carpenter J, Hurd D, Holland JF, Smith BL, Sartor CI, Leung EH, Abrams J, Schilsky RL, Muss HB, Norton L.Randomized trial of dos
  12668651
• Partridge AH, Burstein HJ, Gelman RS, Marcom PK, Winer EP.Do patients participating in clinical trials want to know study results?.J Natl Cancer Inst 2003 Mar 19;95(6):491-2.
  12644548
• Partridge AH, Wang PS, Winer EP, Avorn J.Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.J Clin Oncol 2003 Feb 15;21(4):602-6.
  12586795
• Ligibel JA, Winer EP.Clinical differences among the aromatase inhibitors.Clin Cancer Res 2003 Jan;9(1 Pt 2):473S-9S.
  12538503
• Burstein HJ, Harris LN, Gelman R, Lester SC, Nunes RA, Kaelin CM, Parker LM, Ellisen LW, Kuter I, Gadd MA, Christian RL, Kennedy PR, Borges VF, Bunnell CA, Younger J, Smith BL, Winer EP.Preoperative therapy with trastuzumab and paclitaxel followed by sequ
  12506169
• Skinner CS, Schildkraut JM, Berry D, Calingaert B, Marcom PK, Sugarman J, Winer EP, Iglehart JD, Futreal PA, Rimer BK.Pre-counseling education materials for BRCA testing: does tailoring make a difference?.Genet Test 2002 Summer;6(2):93-105.
  12215248
• Winer EP, Hudis C, Burstein HJ, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP.American Society of Clinical Oncology technology assessment o
  12149306
• Partridge AH, Winer EP.Informing clinical trial participants about study results.JAMA 2002 Jul 17;288(3):363-5.
  12117402
• Partridge AH, Burstein HJ, Winer EP.Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer.J Natl Cancer Inst Monogr 2001(30):135-42.
  11773307
• Winer EP, Burstein HJ.New combinations with Herceptin in metastatic breast cancer.Oncology 2001;61 Suppl 2:50-7.
  11694788
• Bluman LG, Borstelmann NA, Rimer BK, Iglehart JD, Winer EP.Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ.J Womens Health Gend Based Med 2001 Jul-Aug;10(6):589-98.
  11559456
• Sparano JA, Winer EP.Liposomal anthracyclines for breast cancer.Semin Oncol 2001 Aug;28(4 Suppl 12):32-40.
  11552228
• Partridge AH, Bunnell CA, Winer EP.Quality of life issues among women undergoing high-dose chemotherapy for breast cancer.Harrison's Principles of Internal Medicine. 2001 Winter;14:41-50.
• Burstein HJ, Bunnell CA, Winer EP.New cytotoxic agents and schedules for advanced breast cancer.Semin Oncol 2001 Aug;28(4):344-58.
  11498829
• Burstein HJ, Kuter I, Campos SM, Gelman RS, Tribou L, Parker LM, Manola J, Younger J, Matulonis U, Bunnell CA, Partridge AH, Richardson PG, Clarke K, Shulman LN, Winer EP.Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing m
  11352965
• Warren Burhenne LJ, Wood SA, D'Orsi CJ, Feig SA, Kopans DB, O'Shaughnessy KF, Sickles EA, Tabar L, Vyborny CJ, Castellino RA.Potential contribution of computer-aided detection to the sensitivity of screening mammography.Radiology 2000 May;215(2):554-62.
  10796939
• Burstein HJ, Manola J, Younger J, Parker LM, Bunnell CA, Scheib R, Matulonis UA, Garber JE, Clarke KD, Shulman LN, Winer EP.Docetaxel administered on a weekly basis for metastatic breast cancer.J Clin Oncol 2000 Mar;18(6):1212-9.
  10715290
• Goss PE, Winer EP, Tannock IF, Schwartz LH.Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients. North American Vorozole St
  10458218
• Tengs TO, Winer EP, Paddock S, Aguilar-Chavez O, Berry DA.Testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes: a decision analysis.Med Decis Making 1998 Oct-Dec;18(4):365-75.
  10372578
• Winer EP, Lindley C, Hardee M, Sawyer WT, Brunatti C, Borstelmann NA, Peters W.Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support.Psychooncology 1999 Mar-Apr;8(2):167-76.
  10335560
• Bluman LG, Rimer BK, Berry DA, Borstelmann N, Iglehart JD, Regan K, Schildkraut J, Winer EP.Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.J Clin Oncol 1999 Mar;17(3):1040-6.
  10071299
• Havlin KA, Ramirez MJ, Legler CM, Harris LN, Matulonis UA, Hohneker JA, Hayes DF, Winer EP.Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer.Cancer Chemother Ph
  9923543
• Bunnell CA, Winer EP.Oral 5-FU analogues in the treatment of breast cancer.Oncology (Huntingt) 1998 Oct;12(10 Suppl 7):39-43.
  9830624
• Warmuth MA, Bowen G, Prosnitz LR, Chu L, Broadwater G, Peterson B, Leight G, Winer EP.Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey.Cancer 1998 Oct 1;83(7):1362-8.
  9762937
• Iglehart JD, Miron A, Rimer BK, Winer EP, Berry D, Shildkraut MJ.Overestimation of hereditary breast cancer risk.Ann Surg 1998 Sep;228(3):375-84.
  9742920
• Thomason TE, McCune JS, Bernard SA, Winer EP, Tremont S, Lindley CM.Cancer pain survey: patient-centered issues in control.J Pain Symptom Manage 1998 May;15(5):275-84.
  9654832
• Lindley C, Vasa S, Sawyer WT, Winer EP.Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer.J Clin Oncol 1998 Apr;16(4):1380-7.
  9552041
• Demark-Wahnefried W, Hars V, Conaway MR, Havlin K, Rimer BK, McElveen G, Winer EP.Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy.Am J Clin Nutr 1997 May;65(5):1495-501.
  9129482
• Demark-Wahnefried W, Rimer BK, Winer EP.Weight gain in women diagnosed with breast cancer.J Am Diet Assoc 1997 May;97(5):519-26, 529; quiz 527-8.
  9145091
• Warmuth MA, Sutton LM, Winer EP.A review of hereditary breast cancer: from screening to risk factor modification.Am J Med 1997 Apr;102(4):407-15.
  9217624
• Sutton LM, Warmuth MA, Petros WP, Winer EP.Pharmacokinetics and clinical impact of all-trans retinoic acid in metastatic breast cancer: a phase II trial.Cancer Chemother Pharmacol 1997;40(4):335-41.
  9225952